INTERVENTION 1:	Intervention	0
Nipple Reconstruction Cylinder	Intervention	1
Nipple reconstruction: BiodesignÂ® Nipple Reconstruction Cylinder	Intervention	2
Inclusion Criteria:	Eligibility	0
Patient presents with a history of breast cancer, having previously completed either uni- or bi-lateral breast removal and reconstruction.	Eligibility	1
patient	HADO:0000008,OAE:0001817	0-7
history	BFO:0000182	24-31
breast cancer	DOID:1612	35-48
breast	UBERON:0000310	35-41
breast	UBERON:0000310	104-110
Patient presents with a desire to obtain nipple reconstruction	Eligibility	2
patient	HADO:0000008,OAE:0001817	0-7
Patient is at least 18 years of age	Eligibility	3
patient	HADO:0000008,OAE:0001817	0-7
age	PATO:0000011	32-35
And other inclusion criteria	Eligibility	4
Exclusion Criteria:	Eligibility	5
Patient is not medically fit enough for surgery under local anesthesia	Eligibility	6
patient	HADO:0000008,OAE:0001817	0-7
surgery	OAE:0000067	40-47
Patient is currently smoking, using tobacco products, or nicotine products (i.e. patch, gum, or nasal spray)	Eligibility	7
patient	HADO:0000008,OAE:0001817	0-7
nicotine	CHEBI:18723	57-65
Patient is pregnant, breastfeeding or planning further pregnancy during the study period	Eligibility	8
patient	HADO:0000008,OAE:0001817	0-7
Patient has physical allergies or cultural objections to the receipt of porcine products	Eligibility	9
patient	HADO:0000008,OAE:0001817	0-7
And other exclusion criteria	Eligibility	10
Outcome Measurement:	Results	0
Percent Nipple Projection at 12 Months Compared to Baseline (1 Week Post-procedure)	Results	1
percent	UO:0000187	0-7
week	UO:0000034	63-67
[Not Specified]	Results	2
Time frame: 12 months	Results	3
time	PATO:0000165	0-4
Results 1:	Results	4
Arm/Group Title: Nipple Reconstruction Cylinder	Results	5
Arm/Group Description: Nipple reconstruction: Biodesign   Nipple Reconstruction Cylinder	Results	6
Overall Number of Participants Analyzed: 44	Results	7
Overall Number of Units Analyzed	Results	8
Type of Units Analyzed: Nipples  Mean (Standard Deviation)Unit of Measure: percentage of projection vs baseline: 37.3         (17.5)	Results	9
mean	BAO:0002173	33-37
standard deviation	BAO:0002176	39-57
Adverse Events 1:	Adverse Events	0
Total: 1/50 (2.00%)	Adverse Events	1
Metastatic breast cancer  1/50 (2.00%)	Adverse Events	2
breast cancer	DOID:1612	11-24
